Cellular Responses to the Membrane Attack Complex
暂无分享,去创建一个
[1] H. Rus,et al. Sublytic complement attack induces cell cycle in oligodendrocytes. , 1996, Journal of immunology.
[2] C. Alpers,et al. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. , 1996, Kidney international.
[3] J. Platt,et al. Complement-mediated regulation of tissue factor activity in endothelium , 1995, The Journal of experimental medicine.
[4] P. Sims,et al. Induction of cellular procoagulant activity by the membrane attack complex of complement. , 1995, Seminars in cell biology.
[5] L. Matis,et al. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[6] A. Whorton,et al. S-nitrosoglutathione reversibly inhibits GAPDH by S-nitrosylation. , 1995, The American journal of physiology.
[7] Z. Fishelson,et al. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis. , 1995, Journal of immunology.
[8] B. Morgan,et al. Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack. , 1995, Immunology.
[9] L. Mahadevan,et al. Parallel signal processing among mammalian MAPKs. , 1995, Trends in biochemical sciences.
[10] C. Mold,et al. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes. , 1994, Journal of immunology.
[11] J. Schofer,et al. Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. , 1994, European heart journal.
[12] J. Halperin,et al. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells , 1994, The Journal of experimental medicine.
[13] A. F. Esser,et al. The membrane attack complex of complement. Assembly, structure and cytotoxic activity. , 1994, Toxicology.
[14] H. Rus,et al. Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal complement complexes. , 1994, The Journal of biological chemistry.
[15] G. Hänsch,et al. Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex. , 1994, Experimental nephrology.
[16] F. Moore. Therapeutic regulation of the complement system in acute injury states. , 1994, Advances in immunology.
[17] M. Hallett,et al. Cross‐linking of CD59 and of other glycosyl phosphatidylinositol‐anchored molecules on neutrophils triggers cell activation via tyrosine kinase , 1993, European journal of immunology.
[18] H. Rus,et al. Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. , 1993, Journal of immunology.
[19] J. Halperin,et al. Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells. , 1993, The Journal of clinical investigation.
[20] P. Sims,et al. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. , 1993, The Journal of biological chemistry.
[21] B. Jahn,et al. Interaction of the terminal complement components C5b-9 with synovial fibroblasts: binding to the membrane surface leads to increased levels in collagenase-specific mRNA. , 1993, Immunology.
[22] H. Rus,et al. Generation of diacylglycerol and ceramide during homologous complement activation. , 1993, Journal of immunology.
[23] T. Ortel,et al. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. , 1993, Blood.
[24] S. J. Elliott,et al. The contribution of increased collagen synthesis to human glomerulosclerosis: a quantitative analysis of alpha 2IV collagen mRNA expression by competitive polymerase chain reaction , 1992, The Journal of experimental medicine.
[25] Z. Fishelson,et al. Complement membrane attack complexes induce in human leukemic cells rapid expression of large proteins (L-CIP). , 1992, Molecular immunology.
[26] Z. Fishelson,et al. Sublytic complement attack protects tumor cells from lytic doses of antibody and complement , 1992, European journal of immunology.
[27] P. Ward,et al. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. , 1992, Journal of immunology.
[28] B. Morgan. Effects of the membrane attack complex of complement on nucleated cells. , 1992, Current topics in microbiology and immunology.
[29] W. Rosse,et al. Paroxysmal nocturnal hemoglobinuria. , 1992, Current topics in microbiology and immunology.
[30] S. Ruddy,et al. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. , 2010, Arthritis and rheumatism.
[31] P. Sims,et al. Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. , 1991, Blood.
[32] P. Sims,et al. The response of human platelets to activated components of the complement system. , 1991, Immunology today.
[33] A. F. Esser. Big MAC attack: complement proteins cause leaky patches. , 1991, Immunology today.
[34] S Bhakdi,et al. Complement lysis: a hole is a hole. , 1991, Immunology today.
[35] C. Koski,et al. In vitro demyelination by serum antibody from patients with guillain‐barré syndrome requires terminal complement complexes , 1991, Annals of neurology.
[36] J. Luzio,et al. Ectocytosis caused by sublytic autologous complement attack on human neutrophils. The sorting of endogenous plasma-membrane proteins and lipids into shed vesicles. , 1991, The Biochemical journal.
[37] J. Volanakis,et al. Molecular genetics, structure, and function of C-reactive protein , 1991, Immunologic research.
[38] J. Dankert,et al. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites. , 1990, Journal of Immunology.
[39] S. Meri,et al. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. , 1990, Immunology.
[40] M. Shin,et al. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. , 1990, Journal of immunology.
[41] P. Sims,et al. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. , 1990, Journal of immunology.
[42] G. Moretto,et al. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. , 1990, The New England journal of medicine.
[43] C. Esmon,et al. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. , 1990, The Journal of biological chemistry.
[44] J. Luzio,et al. Transfer of preformed terminal C5b-9 complement complexes into the outer membrane of viable gram-negative bacteria: effect on viability and integrity. , 1990, Biochemistry.
[45] B. W. van der Meer,et al. Complement proteins C5b-9 induce transbilayer migration of membrane phospholipids. , 1989, Biophysical journal.
[46] S. Binder,et al. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. , 1989, Journal of immunology.
[47] P. Sims,et al. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. , 1989, The Journal of biological chemistry.
[48] A. Campbell,et al. Normal rat serum cytotoxicity against syngeneic oligodendrocytes Complement activation and attack in the absence of anti-myelin antibodies , 1989, Journal of the Neurological Sciences.
[49] P. Sims,et al. The secretory release reaction initiated by complement proteins C5b-9 occurs without platelet aggregation through glycoprotein IIb-IIIa. , 1989, Blood.
[50] B. Morgan,et al. In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium. , 1988, Clinical and experimental immunology.
[51] M. Shin,et al. Hydrolysis of myelin basic protein in human myelin by terminal complement complexes. , 1988, The Journal of biological chemistry.
[52] P. Sims,et al. Complement C5b-9-stimulated platelet secretion is associated with a Ca2+-initiated activation of cellular protein kinases. , 1987, The Journal of biological chemistry.
[53] E. Ritz,et al. Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. , 1987, Kidney international.
[54] J. Dankert,et al. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. , 1987, Journal of immunology.
[55] M. Betz,et al. Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. , 1987, International archives of allergy and applied immunology.
[56] W. Seeger,et al. Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. , 1986, Journal of immunology.
[57] P. Sims,et al. Repolarization of the membrane potential of blood platelets after complement damage: evidence for a Ca++ -dependent exocytotic elimination of C5b-9 pores , 1986 .
[58] M. Shin,et al. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+. , 1986, Journal of immunology.
[59] H. Rus,et al. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque. , 1986, Atherosclerosis.
[60] J. Dankert,et al. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis. , 1986, Journal of immunology.
[61] A. Campbell,et al. The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium. , 1985, The Biochemical journal.
[62] A. Campbell,et al. Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack , 1985, Nature.
[63] M. Shin,et al. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9. , 1985, Journal of immunology.
[64] B. Morgan,et al. 2-Chloroadenosine inhibits complement-induced reactive oxygen metabolite production and recovery of human polymorphonuclear leucocytes attacked by complement. , 1985, Biochemical and biophysical research communications.
[65] M. Betz,et al. Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. , 1984, Journal of immunology.
[66] M. Shin,et al. Elimination of complement channels from the plasma membranes of U937, a nucleated mammalian cell line: temperature dependence of the elimination rate. , 1983, Journal of immunology.
[67] S. Bhakdi,et al. Membrane damage by complement. , 1983, Biochimica et biophysica acta.
[68] M. Shin,et al. Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[69] T. Takenawa,et al. Role of Ca2+ in phosphatidylinositol response and arachidonic acid release in formylated tripeptide- or Ca2+ ionophore A23187-stimulated guinea pig neutrophils. , 1983, Journal of immunology.
[70] L. McManus,et al. Complement localization in ischemic baboon myocardium. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[71] M. Shin,et al. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[72] N. Day,et al. Antibody-independent complement activation by myelin via the classical complement pathway , 1982, The Journal of experimental medicine.
[73] D. Koffler,et al. Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis , 1981, The Journal of experimental medicine.
[74] R. Levine,et al. How complement kills E. coli. I. Location of the lethal lesion. , 1981, Journal of immunology.
[75] M. Polley,et al. The human complement system in thrombin-mediated platelet function , 1978, The Journal of experimental medicine.
[76] H. Müller-Eberhard,et al. A BLOOD COAGULATION ABNORMALITY IN RABBITS DEFICIENT IN THE SIXTH COMPONENT OF COMPLEMENT (C6) AND ITS CORRECTION BY PURIFIED C6 , 1971, The Journal of experimental medicine.
[77] H. Green,et al. THE ACTION OF ANTIBODY AND COMPLEMENT ON MAMMALIAN CELLS * , 1960, Annals of the New York Academy of Sciences.
[78] H. Green,et al. EFFECT OF ANTIBODY AND COMPLEMENT ON PERMEABILITY CONTROL IN ASCITES TUMOR CELLS AND ERYTHROCYTES , 1959, The Journal of experimental medicine.